|
|
FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer
Violaine Randrian
,
Simon Pernot
,
Karine Le Malicot
,
Vittorio Catena
,
Isabelle Baumgaertner
et al.
Article dans une revue
hal-03906999v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Stefano Kim
,
Eric François
,
Thierry André
,
Emmanuelle Samalin
,
Marine Jary
et al.
Article dans une revue
hal-01863908v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects
Simon Pernot
,
Cecile Badoual
,
Magali Terme
,
Florence Castan
,
Aurelie Cazes
et al.
Article dans une revue
hal-01579145v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)
Alexandra Lapeyre-Prost
,
Simon Pernot
,
Julie Sigrand
,
Karine Le Malicot
,
Florence Mary
et al.
Article dans une revue
hal-03284418v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|